CrossRef Cited-by Linking Search Results

This Article:

has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking:

  • LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug Phenformin
    David B. Shackelford, Evan Abt, Laurie Gerken, Debbie S. Vasquez, Atsuko Seki, Mathias Leblanc, Liu Wei, Michael C. Fishbein, Johannes Czernin, Paul S. Mischel, and Reuben J. Shaw
    Cancer Cell (2013) 23 :143
  • Metformin and the thyroid: some questions still remain
    Maria Alevizaki
    Clinical Endocrinology (2013) 78 :503
  • Clinical management of obese patients with cancer
    Wenjing Tao and Jesper Lagergren
    Nature Reviews Clinical Oncology (2013) 10 :519
  • Adipose tissue and adipocytes support tumorigenesis and metastasis
    Kristin M. Nieman, Iris L. Romero, Bennett Van Houten, and Ernst Lengyel
    Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2013) :
  • Metformin: an old drug with new potential
    Joud Hajjar, Mouhammed Amir Habra, and Aung Naing
    Expert Opinion on Investigational Drugs (2013) :1
  • Quels bénéfices antitumoraux attendre de la metformine ?
    Emmanuel Beck and André J. Scheen
    Annales d'Endocrinologie (2013) 74 :137
  • Diabetes and Cancer—An AACE/ACE Consensus Statement
    Yehuda Handelsman, Derek LeRoith, Zachary T. Bloomgarden, Samuel Dagogo-Jack, Daniel Einhorn, Alan J. Garber, George Grunberger, R. Mack Harrell, Robert F. Gagel, Harold E. Lebovitz, Janet B. McGill, and Charles H. Hennekens
    Endocrine Practice (2013) 19 :675
  • Epithelial cancers in the post-genomic era: should we reconsider our lifestyle?
    Jeff M. P. Holly, Li Zeng, and Claire M. Perks
    Cancer and Metastasis Reviews (2013) :
  • Calorie restriction and cancer prevention: a mechanistic perspective
    Stephen D Hursting, Sarah M Dunlap, Nikki A Ford, Marcie J Hursting, and Laura M Lashinger
    Cancer & Metabolism (2013) 1 :10
  • Obesity and Insulin Resistance in Breast Cancer: Are Clinical Trials Needed?
    Pamela J. Goodwin
    Breast Diseases: A Year Book Quarterly (2012) 23 :310
  • Metformin is synthetically lethal with glucose withdrawal in cancer cells
    Javier A. Menendez, Cristina Oliveras-Ferraros, Sílvia Cufí, Bruna Corominas-Faja, Jorge Joven, Begoña Martin-Castillo, and Alejandro Vazquez-Martin
    Cell Cycle (2012) 11 :2782
  • Metformin and cancer
    Christos V. Rizos and Moses S. Elisaf
    European Journal of Pharmacology (2013) 705 :96
  • Obesity and cancer risk: evidence, mechanisms, and recommendations
    Ivana Vucenik and Joseph P. Stains
    Annals of the New York Academy of Sciences (2012) 1271 :37
  • Metformin inhibition of mTORC1 activation, DNA synthesis and proliferation in pancreatic cancer cells: Dependence on glucose concentration and role of AMPK
    James Sinnett-Smith, Krisztina Kisfalvi, Robert Kui, and Enrique Rozengurt
    Biochemical and Biophysical Research Communications (2013) 430 :352
  • A Twenty-First Century Cancer Epidemic Caused by Obesity: The Involvement of Insulin, Diabetes, and Insulin-Like Growth Factors
    Rosalyne L. Westley and Felicity E. B. May
    International Journal of Endocrinology (2013) 2013 :1
  • Postmenopausal breast cancer, androgens, and aromatase inhibitors
    C. Campagnoli, P. Pasanisi, I. Castellano, C. Abbà, T. Brucato, and F. Berrino
    Breast Cancer Research and Treatment (2013) 139 :1
  • Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients
    S. Jiralerspong, E. S. Kim, W. Dong, L. Feng, G. N. Hortobagyi, and S. H. Giordano
    Annals of Oncology (2013) :
  • Insulin Therapy and Cancer in Type 2 Diabetes
    Edoardo Mannucci
    ISRN Endocrinology (2012) 2012 :1
  • Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK
    Y Storozhuk, S N Hopmans, T Sanli, C Barron, E Tsiani, J-C Cutz, G Pond, J Wright, G Singh, and T Tsakiridis
    British Journal of Cancer (2013) 108 :2021
  • Chemoprevention of breast cancer
    Julia A Files, Daniela L Stan, Summer V Allen, and Sandhya Pruthi
    Women's Health (2012) 8 :635
  • Metformin and breast cancer risk: a meta-analysis and critical literature review
    Nananda F. Col, Leslie Ochs, Vicky Springmann, Aaron K. Aragaki, and Rowan T. Chlebowski
    Breast Cancer Research and Treatment (2012) 135 :639
  • Current Phase II clinical data for ridaforolimus in cancer
    Anna Spreafico and Helen J Mackay
    Expert Opinion on Investigational Drugs (2013) :1
  • Journal Club
    Breast Care (2012) 7 :418
  • Javaslat a metformin idült vesebetegségben történő alkalmazásának módosítására
    Zoltán Balogh and János Mátyus
    Orvosi Hetilap (2012) 153 :1527